(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic aci...
Gespeichert in:
Veröffentlicht in: | Food & function 2020-10, Vol.11 (1), p.8811-8824 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8824 |
---|---|
container_issue | 1 |
container_start_page | 8811 |
container_title | Food & function |
container_volume | 11 |
creator | Álvarez Cilleros, David López-Oliva, María Elvira Martín, María Ángeles Ramos, Sonia |
description | Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role.
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. |
doi_str_mv | 10.1039/d0fo01805h |
format | Article |
fullrecord | <record><control><sourceid>proquest_rsc_p</sourceid><recordid>TN_cdi_rsc_primary_d0fo01805h</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2452318685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</originalsourceid><addsrcrecordid>eNp9ksFuFSEUhidGY5vajXsNxk01jmVgGGBpamtNGu9Gk-4mDDAzNAxMgUl6fQLXPpdP4ZPI9LY1cSEbDvk__vycQ1E8r-D7CmJ-rGDvYcUgGR8V-wjWqGwIvHx8X9e82SsOY7yCeWHOGWdPiz2MOOGM8P3i19HvHz_flKezkSJpORoHhFMgjRpIb70zEkw6ic5bkzRA73CpzLhVwd9sO-2--6wLaRSYg8_XExCDMC4mMJphBINdpI_61tGa2c_ebqOQchTBKF0apxapFTCut2KaRDLe5QMI2gm7Ot6YKRdp6RYrApDa2piTBb9k7y-by7I-njED0QyZt8YNz4onvbBRH97tB8W3s9OvJ-flxebT55MPF6XMHUil7glhmFJKug4ymfuCcM8VbJBmDSEIVVBy1PMO9lTXlFHOlaSQs1pWtaINPiiOdr454_WiY2onE9d4wmm_xBbVdc0ohXhFX_-DXvkl5LwrRRCuWMNIpt7uKBl8jEH37Rzy28O2rWC7jrn9CM82t2M-z_DLO8ulm7R6QO-HmoEXOyBE-aD-_SdZf_U_vZ1Vj_8AXXS69A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2452318685</pqid></control><display><type>article</type><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><source>MEDLINE</source><source>Royal Society Of Chemistry Journals 2008-</source><creator>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</creator><creatorcontrib>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</creatorcontrib><description>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role.
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</description><identifier>ISSN: 2042-6496</identifier><identifier>EISSN: 2042-650X</identifier><identifier>DOI: 10.1039/d0fo01805h</identifier><identifier>PMID: 32959859</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Acids ; Adhesion ; Blood Glucose - metabolism ; c-Jun protein ; Catechin - pharmacology ; Cell adhesion ; Cell adhesion & migration ; Cell adhesion molecules ; Cell Culture Techniques ; Colon - metabolism ; Cytokines ; Diabetes ; Diabetes mellitus ; Diabetic Nephropathies - etiology ; Diabetic Nephropathies - prevention & control ; Dihydroxybenzoic acid ; Dihydroxyphenylacetic acid ; Epicatechin ; Extracellular signal-regulated kinase ; Flavonoids ; Glucose ; Humans ; Hydroxybenzoates - pharmacology ; Hyperglycemia ; Inflammation ; Intercellular adhesion molecule 1 ; Interleukin 6 ; JNK protein ; Kidney diseases ; Kidney Tubules - cytology ; Kidney Tubules - drug effects ; Kinases ; Lipopolysaccharides ; Lipopolysaccharides - metabolism ; Metabolites ; Monocyte chemoattractant protein ; Monocyte chemoattractant protein 1 ; Monocytes ; NAD(P)H oxidase ; NADPH Oxidase 4 - metabolism ; Oxidative stress ; p38 Mitogen-Activated Protein Kinases - metabolism ; Pathogenesis ; Phenolic acids ; Phenols ; Pretreatment ; Protective Agents - pharmacology ; Protein kinase ; Proteins ; Signal Transduction - drug effects ; Transcription factors ; Tumor necrosis factor-TNF ; Tumors</subject><ispartof>Food & function, 2020-10, Vol.11 (1), p.8811-8824</ispartof><rights>Copyright Royal Society of Chemistry 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</citedby><cites>FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</cites><orcidid>0000-0003-2649-2616 ; 0000-0002-0615-9149</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32959859$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Álvarez Cilleros, David</creatorcontrib><creatorcontrib>López-Oliva, María Elvira</creatorcontrib><creatorcontrib>Martín, María Ángeles</creatorcontrib><creatorcontrib>Ramos, Sonia</creatorcontrib><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><title>Food & function</title><addtitle>Food Funct</addtitle><description>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role.
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</description><subject>Acids</subject><subject>Adhesion</subject><subject>Blood Glucose - metabolism</subject><subject>c-Jun protein</subject><subject>Catechin - pharmacology</subject><subject>Cell adhesion</subject><subject>Cell adhesion & migration</subject><subject>Cell adhesion molecules</subject><subject>Cell Culture Techniques</subject><subject>Colon - metabolism</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic Nephropathies - prevention & control</subject><subject>Dihydroxybenzoic acid</subject><subject>Dihydroxyphenylacetic acid</subject><subject>Epicatechin</subject><subject>Extracellular signal-regulated kinase</subject><subject>Flavonoids</subject><subject>Glucose</subject><subject>Humans</subject><subject>Hydroxybenzoates - pharmacology</subject><subject>Hyperglycemia</subject><subject>Inflammation</subject><subject>Intercellular adhesion molecule 1</subject><subject>Interleukin 6</subject><subject>JNK protein</subject><subject>Kidney diseases</subject><subject>Kidney Tubules - cytology</subject><subject>Kidney Tubules - drug effects</subject><subject>Kinases</subject><subject>Lipopolysaccharides</subject><subject>Lipopolysaccharides - metabolism</subject><subject>Metabolites</subject><subject>Monocyte chemoattractant protein</subject><subject>Monocyte chemoattractant protein 1</subject><subject>Monocytes</subject><subject>NAD(P)H oxidase</subject><subject>NADPH Oxidase 4 - metabolism</subject><subject>Oxidative stress</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Pathogenesis</subject><subject>Phenolic acids</subject><subject>Phenols</subject><subject>Pretreatment</subject><subject>Protective Agents - pharmacology</subject><subject>Protein kinase</subject><subject>Proteins</subject><subject>Signal Transduction - drug effects</subject><subject>Transcription factors</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumors</subject><issn>2042-6496</issn><issn>2042-650X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksFuFSEUhidGY5vajXsNxk01jmVgGGBpamtNGu9Gk-4mDDAzNAxMgUl6fQLXPpdP4ZPI9LY1cSEbDvk__vycQ1E8r-D7CmJ-rGDvYcUgGR8V-wjWqGwIvHx8X9e82SsOY7yCeWHOGWdPiz2MOOGM8P3i19HvHz_flKezkSJpORoHhFMgjRpIb70zEkw6ic5bkzRA73CpzLhVwd9sO-2--6wLaRSYg8_XExCDMC4mMJphBINdpI_61tGa2c_ebqOQchTBKF0apxapFTCut2KaRDLe5QMI2gm7Ot6YKRdp6RYrApDa2piTBb9k7y-by7I-njED0QyZt8YNz4onvbBRH97tB8W3s9OvJ-flxebT55MPF6XMHUil7glhmFJKug4ymfuCcM8VbJBmDSEIVVBy1PMO9lTXlFHOlaSQs1pWtaINPiiOdr454_WiY2onE9d4wmm_xBbVdc0ohXhFX_-DXvkl5LwrRRCuWMNIpt7uKBl8jEH37Rzy28O2rWC7jrn9CM82t2M-z_DLO8ulm7R6QO-HmoEXOyBE-aD-_SdZf_U_vZ1Vj_8AXXS69A</recordid><startdate>20201021</startdate><enddate>20201021</enddate><creator>Álvarez Cilleros, David</creator><creator>López-Oliva, María Elvira</creator><creator>Martín, María Ángeles</creator><creator>Ramos, Sonia</creator><general>Royal Society of Chemistry</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2649-2616</orcidid><orcidid>https://orcid.org/0000-0002-0615-9149</orcidid></search><sort><creationdate>20201021</creationdate><title>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</title><author>Álvarez Cilleros, David ; López-Oliva, María Elvira ; Martín, María Ángeles ; Ramos, Sonia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-ef55837775bb08c00323f9d062e86552210c92f9b0f7e478799dc70984c14d763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Acids</topic><topic>Adhesion</topic><topic>Blood Glucose - metabolism</topic><topic>c-Jun protein</topic><topic>Catechin - pharmacology</topic><topic>Cell adhesion</topic><topic>Cell adhesion & migration</topic><topic>Cell adhesion molecules</topic><topic>Cell Culture Techniques</topic><topic>Colon - metabolism</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic Nephropathies - prevention & control</topic><topic>Dihydroxybenzoic acid</topic><topic>Dihydroxyphenylacetic acid</topic><topic>Epicatechin</topic><topic>Extracellular signal-regulated kinase</topic><topic>Flavonoids</topic><topic>Glucose</topic><topic>Humans</topic><topic>Hydroxybenzoates - pharmacology</topic><topic>Hyperglycemia</topic><topic>Inflammation</topic><topic>Intercellular adhesion molecule 1</topic><topic>Interleukin 6</topic><topic>JNK protein</topic><topic>Kidney diseases</topic><topic>Kidney Tubules - cytology</topic><topic>Kidney Tubules - drug effects</topic><topic>Kinases</topic><topic>Lipopolysaccharides</topic><topic>Lipopolysaccharides - metabolism</topic><topic>Metabolites</topic><topic>Monocyte chemoattractant protein</topic><topic>Monocyte chemoattractant protein 1</topic><topic>Monocytes</topic><topic>NAD(P)H oxidase</topic><topic>NADPH Oxidase 4 - metabolism</topic><topic>Oxidative stress</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Pathogenesis</topic><topic>Phenolic acids</topic><topic>Phenols</topic><topic>Pretreatment</topic><topic>Protective Agents - pharmacology</topic><topic>Protein kinase</topic><topic>Proteins</topic><topic>Signal Transduction - drug effects</topic><topic>Transcription factors</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Álvarez Cilleros, David</creatorcontrib><creatorcontrib>López-Oliva, María Elvira</creatorcontrib><creatorcontrib>Martín, María Ángeles</creatorcontrib><creatorcontrib>Ramos, Sonia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Food & function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez Cilleros, David</au><au>López-Oliva, María Elvira</au><au>Martín, María Ángeles</au><au>Ramos, Sonia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>(−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling</atitle><jtitle>Food & function</jtitle><addtitle>Food Funct</addtitle><date>2020-10-21</date><risdate>2020</risdate><volume>11</volume><issue>1</issue><spage>8811</spage><epage>8824</epage><pages>8811-8824</pages><issn>2042-6496</issn><eissn>2042-650X</eissn><abstract>Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease. Epicatechin (EC) and main colonic phenolic acids derived from flavonoid intake, such as 2,3-dihydroxybenzoic acid (DHBA), 3,4-dihydroxyphenylacetic acid (DHPAA) and 3-hydroxyphenylpropionic acid (HPPA), have been suggested to exert beneficial effects in diabetes. This study was aimed at investigating whether the mentioned compounds could prevent inflammation in renal proximal tubular NRK-52E cells induced by high glucose and lipopolysaccharide (LPS). Pre-treatment of cells with EC and DHBA (5 μM) reverted the enhanced levels of pro-inflammatory cytokines, such as tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and monocyte chemoattractant protein 1 (MCP-1), activated by high glucose and LPS. Additionally, EC and DHBA pre-incubation reduced the increased values of adhesion molecules, namely, intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1), as well as those of mitogen-activated protein kinases (MAPKs) [extracellular signal-regulated kinase (ERK), -c-jun N-terminal kinase (JNK) and -p38 protein kinase (p38)] activated by the high glucose and LPS challenge. Thus, in EC and DHBA pre-treated cells ICAM-1, p-ERK and p-JNK were returned to control values, and VCAM-1 and p-p38 levels were reduced by ∼20 and 25%, respectively, when compared to high glucose plus LPS-stimulated cells. Likewise, pre-treatment with EC and DHBA protected against high glucose plus LPS-triggered oxidative stress by preventing increased ROS and NADPH oxidase 4 (NOX-4) levels (∼25 and 45% reduction, respectively). By using specific inhibitors of p38 and NOX-4, the participation of both proteins in EC- and DHBA-mediated protection against inflammation and associated oxidative stress was shown. Taken together, EC and DHBA exert beneficial effects in renal proximal tubular cells, as they contribute to preventing the inflammatory-induced milieu and the accompanying redox imbalance, playing NOX-4/p38 a crucial role.
Chronic hyperglycaemia and inflammation are present in diabetes and both processes have been related to the pathogenesis of diabetic kidney disease.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>32959859</pmid><doi>10.1039/d0fo01805h</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2649-2616</orcidid><orcidid>https://orcid.org/0000-0002-0615-9149</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2042-6496 |
ispartof | Food & function, 2020-10, Vol.11 (1), p.8811-8824 |
issn | 2042-6496 2042-650X |
language | eng |
recordid | cdi_rsc_primary_d0fo01805h |
source | MEDLINE; Royal Society Of Chemistry Journals 2008- |
subjects | Acids Adhesion Blood Glucose - metabolism c-Jun protein Catechin - pharmacology Cell adhesion Cell adhesion & migration Cell adhesion molecules Cell Culture Techniques Colon - metabolism Cytokines Diabetes Diabetes mellitus Diabetic Nephropathies - etiology Diabetic Nephropathies - prevention & control Dihydroxybenzoic acid Dihydroxyphenylacetic acid Epicatechin Extracellular signal-regulated kinase Flavonoids Glucose Humans Hydroxybenzoates - pharmacology Hyperglycemia Inflammation Intercellular adhesion molecule 1 Interleukin 6 JNK protein Kidney diseases Kidney Tubules - cytology Kidney Tubules - drug effects Kinases Lipopolysaccharides Lipopolysaccharides - metabolism Metabolites Monocyte chemoattractant protein Monocyte chemoattractant protein 1 Monocytes NAD(P)H oxidase NADPH Oxidase 4 - metabolism Oxidative stress p38 Mitogen-Activated Protein Kinases - metabolism Pathogenesis Phenolic acids Phenols Pretreatment Protective Agents - pharmacology Protein kinase Proteins Signal Transduction - drug effects Transcription factors Tumor necrosis factor-TNF Tumors |
title | (−)-Epicatechin and the colonic metabolite 2,3-dihydroxybenzoic acid protect against high glucose and lipopolysaccharide-induced inflammation in renal proximal tubular cells through NOX-4/p38 signalling |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A11%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_rsc_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=(%E2%88%92)-Epicatechin%20and%20the%20colonic%20metabolite%202,3-dihydroxybenzoic%20acid%20protect%20against%20high%20glucose%20and%20lipopolysaccharide-induced%20inflammation%20in%20renal%20proximal%20tubular%20cells%20through%20NOX-4/p38%20signalling&rft.jtitle=Food%20&%20function&rft.au=%C3%81lvarez%20Cilleros,%20David&rft.date=2020-10-21&rft.volume=11&rft.issue=1&rft.spage=8811&rft.epage=8824&rft.pages=8811-8824&rft.issn=2042-6496&rft.eissn=2042-650X&rft_id=info:doi/10.1039/d0fo01805h&rft_dat=%3Cproquest_rsc_p%3E2452318685%3C/proquest_rsc_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2452318685&rft_id=info:pmid/32959859&rfr_iscdi=true |